1800 202 8726
Kidney failure and biopsy

Biopsy on Dialysis: — Timing, Safety and Bleeding Risk

Being on dialysis does not automatically rule out a biopsy. It means the team needs to plan around two specific factors — uraemic platelet dysfunction and the heparin used during your dialysis session — and for most patients that planning is straightforward.

Medically reviewed by Dr. Mohammed Imaduddin, Surgical Oncologist, MBBS · MS (General Surgery) · M.Ch (Surgical Oncology) · Last reviewed September 2026

  • Usually possible — Most patients on dialysis can safely have a biopsy when the procedure is planned around the dialysis schedule.
  • Timing is the key — Biopsy is usually scheduled after a dialysis session, once the heparin used in the circuit has cleared and platelet function is at its best.
  • Platelet function, not count — Uraemia impairs how platelets work even when the platelet count looks normal. The team checks function, not count alone.
  • Not an automatic refusal — If you have been told a biopsy is impossible because you are on dialysis, it is worth asking your oncologist specifically why.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Most patients on dialysis can have a biopsy safely. The concern is not dialysis itself — it is that uraemic toxins impair platelet function, and heparin used during the dialysis circuit adds a temporary bleeding risk. Your team manages both by scheduling the biopsy after a dialysis session, once heparin has cleared and platelet function is still improved.

Is a biopsy safe when you are on dialysis?

For most patients, yes — but it requires planning that a standard biopsy does not need.

Renal failure causes a build-up of uraemic toxins in the blood. These toxins impair how platelets stick together and form a clot, even when your platelet count is in the normal range. That is called uraemic platelet dysfunction, and it is the main reason bleeding risk is higher in dialysis patients.

Dialysis removes those toxins and temporarily restores platelet function. That window of improved function is what your team uses to schedule the biopsy more safely.

The decision belongs to your oncologist and nephrologist together. Being on dialysis is a factor they weigh — not a door they close.

What does your team check before booking the biopsy?

  • Platelet function, not just platelet count
  • Clotting profile
  • When your last dialysis session was
  • Which type of dialysis you are on
  • Whether desmopressin is appropriate
  • The planned biopsy site
  • Whether you are pregnant

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Does the timing of your dialysis session matter?

Yes, and for two distinct reasons.

First, haemodialysis uses heparin — a blood thinner — to keep blood moving through the dialysis circuit without clotting. Heparin stays in your system for some hours after the session ends. Performing a biopsy while it is still active raises bleeding risk, so the team waits for it to clear before proceeding.

Second, dialysis improves platelet function by removing uraemic toxins, but that improvement fades as toxins accumulate again before the next session. There is a window where platelet function is at its best.

Your team aims to schedule the biopsy inside that window — after the heparin has cleared but before platelet function has declined again. Your nephrologist and the biopsy team agree on the exact timing together.

Did you know?

Uraemic platelet dysfunction is a condition where platelets cannot stick together properly even when the platelet count is in the normal range.

This is why a blood count alone does not measure bleeding risk in a dialysis patient — and why dialysis timing, not just platelet numbers, shapes when the biopsy is scheduled.

Source: NCCN Clinical Practice Guidelines; ESMO guidance on procedural risk in patients with renal impairment

Explore 102 more Your Result, What Comes Next and Support topics

HUB — Who Can Have a Biopsy? Special Situations

HUB — Your Biopsy Confirmed Cancer

All Your Result, What Comes Next and Support →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can dialysis patients really have a biopsy, or is it too dangerous?

Most dialysis patients can have a biopsy when it is planned carefully. The concern is not that biopsy is prohibited — it is that uraemic platelet dysfunction and heparin from the dialysis circuit both need to be managed. Your team addresses both through scheduling and, where needed, medication. If you have been told a biopsy is not possible, ask whether the concern is a fixed contraindication or one that can be planned around with the right timing and preparation.

My platelet count is normal. Does that mean my bleeding risk is normal too?

Not necessarily. Uraemic toxins impair the way platelets function — how they stick together to stop bleeding — even when the count itself looks fine. Your team checks platelet function, not count alone, when assessing your bleeding risk before a biopsy. A normal count is one piece of reassurance, but it does not settle the question on its own in a patient with renal failure.

How soon after dialysis can a biopsy be done?

There is no single answer that applies to everyone, because it depends on which type of dialysis you are on, how much heparin was used in your session, and how your platelet function responds. Your nephrologist and the biopsy team agree on the timing together based on your specific situation. What they are aiming for is a window where the heparin from your last session has cleared but the benefit to your platelet function from that dialysis is still present.

What is DDAVP and will I need it?

DDAVP is desmopressin, a medicine that temporarily improves how platelets function. It is sometimes given before an invasive procedure in patients with uraemic platelet dysfunction to reduce bleeding risk during and after the biopsy. Whether it is right for you depends on your kidney function, the type of biopsy planned, and your broader medical history. Your nephrologist will decide — it is not used routinely for every dialysis patient, but it is a recognised option when platelet function is a concern.

Does it matter whether I am on haemodialysis or peritoneal dialysis?

Yes. Haemodialysis uses heparin in the circuit to prevent clotting, and that heparin affects bleeding risk for some hours after the session. Peritoneal dialysis does not use systemic heparin in the same way, so the post-session timing calculation is different. Both types share the issue of uraemic platelet dysfunction, which is driven by kidney failure itself rather than by the dialysis method. Tell your team which type you are on if they have not already recorded it.

What should I tell my oncologist at my next appointment?

Tell them you are on dialysis, which type, and how often your sessions run. Ask whether a biopsy is being considered and whether the dialysis schedule has been factored into the plan. Bring your most recent blood results from your nephrologist, including your clotting profile. Ask specifically whether your platelet function has been assessed, not just your platelet count. And ask whether the biopsy team and your dialysis team have coordinated — that coordination is what makes the timing work.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation